# generate_tests\Test mAB\IgG4-K-002.txt
# Generated sample - 10114H|bleselumab|Homo sapiens||H-GAMMA-4 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (232-341) [D3] + CH3 (342-446) [D4])|||||||448|448|||MW undefined|MW undefined| - Trypsin - 25%
LSSVTAADTAVYYCTRPVVR
TYTCNVDHKPSNTK
YGPPCPPCPAPEFEGGPSVFLFPPKPK
TPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAK
VVSVLTVLHQDWLNGK
GLPSSIEK
GFYPSDIAVEWESNGQPENNYK
# Generated sample - 10114H|bleselumab|Homo sapiens||H-GAMMA-4 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (232-341) [D3] + CH3 (342-446) [D4])|||||||448|448|||MW undefined|MW undefined| - Chymotrypsin - 25%
KPSETL
KSGSTY
CTRPVVRY
TSGVHTF
SSVVTVPSSSL
TCNVDHKPSNTKVDKRVESKY
PPKPKDTL
RVVSVL
# Generated sample - 10114H|bleselumab|Homo sapiens||H-GAMMA-4 (VH (1-121) [D1] + CH1 (122-219) [D2] + CH2 (232-341) [D3] + CH3 (342-446) [D4])|||||||448|448|||MW undefined|MW undefined| - Aspecific - 25%
KPSETLSLTCTVSGGSISSPGYYGGWIRQPPGKGLEWIGS
ETLSLTCTVSGGSISSPGYYGGWIRQPPGKGLE
YYGGWIRQPPGKGLEWIGSIYKSGSTYHNPSLKS
TYHNPSLKSRVTISVDTS
RVTISVDTS
KLSSVTAADTAVYYCTRPVVRY
RPVVRYFGWFDPWGQG
LVTVSSASTKGPS
PSVFPLAPCSRSTSESTAALGCLVKDYF
LVKDYFPEPVTVSWNSGALTSGVHTFPA
VKDYFPEPVTVSWNSGALTSGVHTFPAVLQS
SVVTVPSSSLGTKTYTCNVDHKPSNTKVD
NVDHKPSNTKVDKRVESKYGPPCPPCPA
GPSVFLFPP
LMISRTPEVTC
PEVTCVVVDVSQEDPEVQFNWYV
VTCVVVDVSQEDPEVQFNW
REEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSS
FNSTYRVVSVLTVLHQDWLN
KEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQ
YKCKVSNKGLPSSIEK
TTPPVLDSDGSFFLYSRLTV
VLDSDGSFF
VLDSDGSFFLY
LYSRLTV
TVDKSRWQEGNVFSCSVMHEALHNHYTQKS
# Generated sample - 10114L|bleselumab|Homo sapiens||L-KAPPA (V-KAPPA (1-106) [D1] + C-KAPPA (107-213) [D2])|||||||213|213|||MW undefined|MW undefined| - Trypsin - 25%
AIQLTQSPSSLSASVGDR
TVAAPSVFIFPPSDEQLK
# Generated sample - 10114L|bleselumab|Homo sapiens||L-KAPPA (V-KAPPA (1-106) [D1] + C-KAPPA (107-213) [D2])|||||||213|213|||MW undefined|MW undefined| - Chymotrypsin - 25%
EKHKVY
SSPVTKSF
# Generated sample - 10114L|bleselumab|Homo sapiens||L-KAPPA (V-KAPPA (1-106) [D1] + C-KAPPA (107-213) [D2])|||||||213|213|||MW undefined|MW undefined| - Aspecific - 25%
LTQSPSSLSASVGDRVTITCRASQGISSAL
PSSLSASVGDRVTITCRASQGISSALAWYQQ
TCRASQGISSALAWYQQK
ISSALAWYQQKPGKAPKLLIYDASNLES
LESGVPSRFSGSGSGTDFTLTISSLQP
GVPSRFSGSGS
ATYYCQQFNSYPTFGQGTKVEIKRTVAAPSVFIFPPS
YCQQFNSYPTFG
TKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLN
DNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEK
TEQDSKDSTYSLSSTLTLSKADYE
VYACEVTHQGLSSPVTKSFN
ACEVTHQGLSSPVTKSFNRGEC
